Skip to main content
. 2019 Jan 18;14(1):e0210274. doi: 10.1371/journal.pone.0210274

Fig 3. Bromelain treatment suppressed colorectal cancer (CRC) progression in a xenograft mouse model.

Fig 3

(A) The growth rate was slower in the bromelain-treated group in both the HCT116 and HT-29 cell lines. (B, C) The tumor size and tumor weight were significantly reduced to 30% compared to the vehicle-treated group. (D) There was no significant difference in body weights between the vehicle- and bromelain-treated mouse groups. * p<0.05.